Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LR 19052

Next Previous
X
Search
Drug Profile

LR 19052

Alternative Names: LR-19052

Latest Information Update: 20 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LG Chem
  • Class Antihyperglycaemics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preregistration Type 2 diabetes mellitus

Most Recent Events

  • 30 Apr 2024 Preregistration for Type 2 diabetes mellitus in South Korea (unspecified route) (LG Chem pipeline, April 2024)
  • 11 Apr 2024 LR 19052 is available for licensing as of 11 Apr 2024. https://innovation.lgchem.com/ResearchDevelopment/Partnership.do
  • 13 Oct 2020 Phase-III clinical trials in Type 2 diabetes mellitus in South Korea (unspecified route) (LG Chem pipeline, October 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top